Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals.
作者信息
Nobrega de Almeida João, Campos Silvia V, Thomaz Danilo Y, Thomaz Luciana, de Almeida Renato K G, Del Negro Gilda M B, Gimenes Viviane F, Grenfell Rafaella C, Motta Adriana L, Rossi Flávia, Benard Gil
机构信息
Central Laboratory Division- LIM-03, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, 05403-010, Brazil.
Laboratory of Medical Mycology - LIM-53, Hospital das Clínicas FMUSP and Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, São Paulo, 05403-000, Brazil.
出版信息
Emerg Microbes Infect. 2018 Mar 7;7(1):24. doi: 10.1038/s41426-017-0015-8.
Abstract
摘要
相似文献
1
Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals.
Emerg Microbes Infect. 2018 Mar 7;7(1):24. doi: 10.1038/s41426-017-0015-8.
2
First isolation of Candida metapsilosis in Kuwait, an emerging global opportunistic pathogen.
J Mycol Med. 2016 Mar;26(1):46-50. doi: 10.1016/j.mycmed.2015.11.001. Epub 2015 Dec 11.
3
What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.
Mycoses. 2011 Sep;54(5):434-41. doi: 10.1111/j.1439-0507.2010.01960.x. Epub 2010 Oct 29.
4
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.
J Clin Microbiol. 2004 Oct;42(10):4419-31. doi: 10.1128/JCM.42.10.4419-4431.2004.
5
Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
Med Mycol. 2012 Oct;50(7):781-4. doi: 10.3109/13693786.2012.675526. Epub 2012 Apr 12.
6
The first cases of Candida auris candidaemia in Oman.
Mycoses. 2017 Sep;60(9):569-575. doi: 10.1111/myc.12647. Epub 2017 Jul 7.
7
First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen.
Med Mycol. 2010 Mar;48(2):416-20. doi: 10.1080/13693780903114231.
8
[Candida dubliniensis: a novel emerging species].
Ann Biol Clin (Paris). 2007 Jan-Feb;65(1):13-9.
9
Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Microb Pathog. 2018 Feb;115:353-357. doi: 10.1016/j.micpath.2017.12.069. Epub 2017 Dec 29.
10
Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.
J Clin Microbiol. 2008 Mar;46(3):933-8. doi: 10.1128/JCM.02116-07. Epub 2008 Jan 16.
引用本文的文献
1
Case report: osteo-articular infection in a patient with Chronic Granulomatous Disease.
Med Mycol Case Rep. 2024 Oct 31;46:100682. doi: 10.1016/j.mmcr.2024.100682. eCollection 2024 Dec.
2
Spectrum and management of rare /yeast infections in Kuwait in the Middle East.
Ther Adv Infect Dis. 2024 Jul 24;11:20499361241263733. doi: 10.1177/20499361241263733. eCollection 2024 Jan-Dec.
3
The yeast genus Tardiomyces gen. nov. with one new species and two new combinations.
Infection. 2024 Oct;52(5):1799-1812. doi: 10.1007/s15010-024-02229-6. Epub 2024 Apr 4.
4
Clonal Diversity of , , and Isolated from Septicemia and Otomycosis in Bangladesh as Determined by Multilocus Sequence Typing.
J Fungi (Basel). 2023 Jun 12;9(6):658. doi: 10.3390/jof9060658.
5
Candidemia an Emerging Threat.
Iran J Public Health. 2023 Jan;52(1):208-209. doi: 10.18502/ijph.v52i1.11686.
6
Fungal Nomenclature: Managing Change is the Name of the Game.
Open Forum Infect Dis. 2023 Jan 7;10(1):ofac559. doi: 10.1093/ofid/ofac559. eCollection 2023 Jan.
7
Overview on the Infections Related to Rare Species.
Pathogens. 2022 Aug 24;11(9):963. doi: 10.3390/pathogens11090963.
8
Using genomics to understand the mechanisms of virulence and drug resistance in fungal pathogens.
Biochem Soc Trans. 2022 Jun 30;50(3):1259-1268. doi: 10.1042/BST20211123.
9
The Continuing Emergence of as a Pathogenic Fungus: A New Case of Fungemia in a Patient Infected with SARS-CoV-2.
J Fungi (Basel). 2022 Feb 9;8(2):166. doi: 10.3390/jof8020166.
10
Biodiversity and Enzyme Activity of Marine Fungi with 28 New Records from the Tropical Coastal Ecosystems in Vietnam.
Mycobiology. 2021 Dec 26;49(6):559-581. doi: 10.1080/12298093.2021.2008103. eCollection 2021.
本文引用的文献
1
Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points.
Int J Med Microbiol. 2014 Nov;304(8):1192-8. doi: 10.1016/j.ijmm.2014.08.012. Epub 2014 Sep 1.
2
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
Clin Microbiol Infect. 2012 Jul;18(7):E246-7. doi: 10.1111/j.1469-0691.2012.03880.x. Epub 2012 May 8.
3
Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi.
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6241-6. doi: 10.1073/pnas.1117018109. Epub 2012 Mar 27.
4
Biosensor analyzer for BOD index express control on the basis of the yeast microorganisms Candida maltosa, Candida blankii, and Debaryomyces hansenii.
Enzyme Microb Technol. 2012 Apr 5;50(4-5):215-20. doi: 10.1016/j.enzmictec.2012.01.002. Epub 2012 Jan 20.
5
Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
Med Mycol. 2011 Apr;49(3):253-62. doi: 10.3109/13693786.2010.530032. Epub 2010 Nov 2.
6
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.
Nat Protoc. 2008;3(9):1494-500. doi: 10.1038/nport.2008.141.
7
Chemostat cultivation of Candida blankii on sugar cane bagasse hemicellulose hydrolysate.
Biotechnol Bioeng. 1992 Jul;40(3):353-8. doi: 10.1002/bit.260400304.
8
Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains.
J Clin Microbiol. 2001 Oct;39(10):3617-22. doi: 10.1128/JCM.39.10.3617-3622.2001.
9
Development of an insect model for the in vivo pathogenicity testing of yeasts.
FEMS Immunol Med Microbiol. 2000 Feb;27(2):163-9. doi: 10.1111/j.1574-695X.2000.tb01427.x.
10
Five new Candida species.
Mycopathol Mycol Appl. 1968 Dec 31;36(3):257-66. doi: 10.1007/BF02050372.
Zotero 插件